GE HealthCare Technologies Inc.

GEHC Healthcare Medical Devices

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.

69.57 0.78 −1.11%
Market cap
$31.8B
P/E
16.0×
Fwd P/E
14.4×
Dividend yield
0.26%
F-score
4/9
Altman Z
1.96
Beneish M
−2.33
Dividend safety
74/100

GE HealthCare Technologies Inc. (GEHC) Shares outstanding

Alert me on Shares outstanding

GE HealthCare Technologies Inc.'s shares outstanding at the end of fiscal 2025 was $458.0M, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was $454.0M. Over the past ten years it has ranged from $454.0M (fiscal 2022) to $459.0M (fiscal 2024); the current reading is higher than 86% of that period. GE HealthCare Technologies Inc. ranks 7th of 147 Medical Devices companies by shares outstanding.

Shares outstanding, annual

Embed this chart

Annual newest first

Period Shares outstanding Change
FY2025 $458.0M (0.22%)
FY2024 $459.0M 0.22%
FY2023 $458.0M 0.88%
FY2022 $454.0M 0.00%
FY2021 $454.0M (0.22%)
FY2020 $455.0M 0.00%
FY2019 $455.0M —

Quarterly newest first

Period Shares outstanding Change
Jun 2026 $454.0M (0.66%)
Mar 2026 $457.0M (0.22%)
Dec 2025 $458.0M 0.22%
Sep 2025 $457.0M (0.22%)
14 more quarters

Against its own ten years

Low $454.0M High $459.0M
Ten-year median $455.0M
Current reading's percentile 86

Shares outstanding against peers

What Shares outstanding is

Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.

Reported line item

The full definition of Shares outstanding →

More on GEHC